What is an ePAG advocate?
ePAGs stands for European Patient Advocacy Groups. They are non-profit organisation that represents patients of a given rare diseases at the EU-level. They were launched by EURORDIS specifically to integrate ERNs. Hence in 2016, Eurordis and the European rare disease community established the first 24 ePAGs, aligned to the clinical scope of each ERN. Today, the ERNs community counts over 300 ePAGs.
The role of an ePAG is to represent the voice and interests of their patient community within an ERN, in other words to act as the bridge between their community and an ERN’s management team and network of clinicians and researchers. They are thus members of all their ERN’s gorvenance bodies : Board Committee, Executive Committee, and each of every Workgroups. ERNs being fundamentally patient–centred network, ePAGs’ role are crucial to make sure that the patient’s voice and perspective are taken into account when designing and executing new rare diseases projects.
To lean more about ePAGs and what they do, you can consult this EURORDIS webpage.
ePAGs’ functions in an ERN – EURORDIS infography
How and why to become an ePAG advocate?
Becoming an ePAG is open to all rare disease patient organisations (wether EURORDIS members or non-members based in the European Union).
Recruitments of ePAGs are permanent, to ensure that patients are fully represented within the networks’ different projects and governance bodies. The ERN-ITHACA Patient Advisory Board has already elected more than 40 ePAG members but additional applications are always welcome.
Becoming an ERN ePAG means being part of a broader community of patients associations that share your questions and struggles, and that you can become stronger with. You’re also joining a vast network of researchers and clinicians that are experts in rare malformative or neurodevelopmental diseases, with whom you can exchange ideas and perspectives to brainstorm new projects and launch new initiatives to improve the life of those living with a rare disease. To understand what joining our ITHACA community means, you can have a look at our special brochure.
You can also consult EURORDIS’ guide on patients-partnership in rare disease research or their more general flyer on ePAG’s ERN involvment.
Hear also from our Patient Board co-chair Dorica Dan on why she became an ePAG and joined the ITHACA network:
If you are a patient association in the field of ITHACA and are interested in joining the network, you can contact Anne Hugon at anne.hugon@aphp.fr.
The ERN-ITHACA Patient Council & Advisory Board
The ERN-ITHACA Patient Council is the official name for our ePAGs community. At this date, it consists of 40 patient associations, coming from … EU countries, each representing a specific rare disorder:
EU map of our ePAGs community
Overview of the conditions represented in ITHACA
The ERN-ITHACA Patient Advisory Board (PAB) is an elected body consisting of 5 ePAGs. It is part and parcel of ERN-ITHACA’s governance and thus participates in each Workgroup or transversal activities and is represented in both the Executive Committee and the Board. Through this organisation, ITHACA aims to maintain a high degree of cooperation between ePAGs and other ERN stakeholders at all levels of decision making and to ensure that all the ERN activities include patients and their families.
To understand with more details how the PAB works, you can read its Terms of Reference HERE.
Our members can have a look at the EURORDIS guide for ERN Patient Advocates HERE.
Our members
Patient Advisory Board
- Chair: Dorica Dan, Romania
Romanian Prader Willi Association
- Co-chair: Tanja Zdolšek Draksler, Slovenia
IDefine Europe (Kleefstra Syndrome)
- Katarzyna Swieczkowska, Poland
Polish Assocciation for Persons with Intellectual Disability,
- Sue Routledge, United Kingdom
Pitt Hopkins
- Tomasz Grybek, Poland
Borys the Hero Foundation
Patient Council Members
- Ammi Andersson, Sweden – RBU, the Swedish national Federation for children and youth with disabilities
- Ioel Detton, France – Noonan Syndrome Association
- Gabor Pogany, Hungary – Rare Diseases Hungary – HUFERDIS Hungarian Williams Syndrome
- Carole Herman, Amis de ADNP, Paris, FR; caroleheman2012@gmail.com
- Katarzyna Swieczkowska, Polish Assocciation for Persons with Intellectual Disability, Gdansk, PL
- Papatya Alkan, IF International Federation for Spina Bifida and Hydrocephalus, NL/UK
- Pietro Marinelli, Associazione Smith Magenis – ASM17, IT
- Annalisa Scopinaro, Associazione Persone Williams Italia, UNIAMO, IT
- Sandrine Daugy, Génération 22, FR
- Gerritjan Koekkoek, Cdls World federation (Cornelia Delange), NL
- Tomasz Grybek, Borys the Hero Foundation, Gdansk, PL
- Erika Stariha, European Foundation for SATB2-Associated Syndrome, SI
- Nora Leonardi AGO2 Association ago2.org, CH
- Sylvia Roozen International Federation for Spina Bifida and Hydrocephalus, BE
- Inés Fernández, Ulibarri Kleefstra syndrome, SP
- Tanja Zdolsek Kleefstra syndrome IDefine Europe, SI
- Georges Papadopoulosn ANGELMAN SYNDROME GREECE ASSOCIATION, EL
- Alejandro Doval, Asociación KIF1A España, SP
- Ana González Hernández, CTNNB1 Foundation and the Spanish CTNNB1 Association, SP
- Sandra López Cabeza, Asociación Afectados, CDKL5 Global Alliance, SP
- Iuliana Dumitriu, Coffin-Lowry Syndrome, Associtia Sindromul Coffin-Lowry RO
- Vesna Vujičić 22q ex YU, Serbie
- Benoit Fourcroy Spina Bifida FR ASBH Association nationale Spina Bifida et Handicaps Associés – FR
- Claudia Beard: SWAN UK – Genetic Alliance UK – Undiagnoses no names / United Kingdom
- Monica Bertoletti: AIBWS ODV- Beckwith–Wiedemann (BWS) / Italy
- Samantha Carletti: PKS Italia Aps_Pallister-Killian_IT – Pallister-Killian syndrome / Italy
- Andrej Drdul : International Spina Bifida and Hydrocephalus (IF) – Spina Bifida / Slovakia
- Samantha Eisenhauer: FAST-Foundation Angelman Syndrome Therapeutics_FR – Angelman Syndrome / France
- Antje Enekwe : SLO Deutschland e.V – Smith-Lemli-Opitz Syndrome / Deutschland
- Nina Knight : Acrodysostosis Support Research_UK – Acrodysostosis / United Kingdom
- Anne Lawlor: 22q11_IRL – 22q11 / Ireland
- Cristina López García : International Asociación de Afectados CDKL5 – CDKL5-deficiency disorder / Spain
- Eszter Szabo: Corpus Callosum Hungary Foundation Disorder of the Corpus Callosum (CCD) / Hungary
- David Ross : Rare Disease Male Mental Health Support Group ; Mental health: Cowden Syndrome / United Kingdom
- Mary Vasseghi : TSC Tuberous Sclerosis Complex – Tuberous Sclerosis Complex / Ireland
- Kelly Verbruggen: ADNP kids – HVDAS_Belgium – HVDAS, ADNP / Belgium
- Lyndsey Walsh: Rare Diseases Alliance_IRL – RD ultra rare condition / Ireland